Genomic Features of Response to Combination Immunotherapy in Lung Cancer

被引：17
作者：
Frueh, Martin [1 ]
Peters, Solange [2 ]
机构：
[1] Cantonal Hosp St Gallen, Dept Med Oncol Hematol, St Gallen, Switzerland
[2] Univ Hosp Lausanne CHUV, Dept Med Oncol, CH-1011 Lausanne, Switzerland
来源：
CANCER CELL | 2018年 / 33卷 / 05期
关键词：
NIVOLUMAB PLUS IPILIMUMAB; MUTATIONAL LANDSCAPE; CTLA-4; BLOCKADE; OPEN-LABEL; MELANOMA;
D O I：
10.1016/j.ccell.2018.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer.
引用
收藏
页码：791 / 793
页数：3
相关论文
共 50 条
  • [31] The Resistance Mechanisms of Lung Cancer Immunotherapy
    Wang, Fen
    Wang, Shubin
    Zhou, Qing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Combination strategies to maximize the benefits of cancer immunotherapy
    Zhu, Shaoming
    Zhang, Tian
    Zheng, Lei
    Liu, Hongtao
    Song, Wenru
    Liu, Delong
    Li, Zihai
    Pan, Chong-xian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [33] The combination of checkpoint immunotherapy and targeted therapy in cancer
    Karachaliou, Niki
    Gonzalez-Cao, Maria
    Sosa, Aaron
    Berenguer, Jordi
    Paulina Bracht, Jillian Wilhelmina
    Ito, Masaoki
    Rosell, Rafael
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (19) : 1 - 10
  • [34] Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
    Boumber, Yanis
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4689 - 4693
  • [35] Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
    Shen, Yili
    Liu, Zhicong
    Chen, Yi
    Shi, Xuefei
    Dong, Shunli
    Wang, Bin
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2025, 26 (02) : 73 - 83
  • [36] Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
    Suwinski, Rafal
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3315 - 3322
  • [37] Immunotherapy in Lung Cancer
    Du, Lingling
    Herbst, Roy S.
    Morgensztern, Daniel
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 131 - +
  • [38] Immunotherapy for Lung Cancer
    Reinmuth, Niels
    Reck, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (06) : 360 - 368
  • [39] Immunotherapy in lung cancer
    Montenegro, Gabriela Bravo
    Farid, Saira
    Liu, Stephen V.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 718 - 729
  • [40] Immunotherapy for lung cancer
    Steven, Antonius
    Fisher, Scott A.
    Robinson, Bruce W.
    RESPIROLOGY, 2016, 21 (05) : 821 - 833
12345